TSE:I

Intellipharmaceutics International - I Stock Forecast, Price & News

Add

Compare

Today's Range: N/A
50-Day Range: C$3.23
▼
C$3.23
52-Week Range: N/A

Volume: 7,625 shs
Average Volume: 16,872 shs
Market Capitalization: C$97.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Intellipharmaceutics International

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

Receive I Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

I Stock News Headlines

January 13, 2023 | finance.yahoo.com

Intellipharmaceutics International Inc. (IPCIF)

August 30, 2022 | thestreet.com

Changes at the Top for Endo Could Benefit Its Smaller Partners

April 1, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.

August 23, 2022 | reuters.com

Intellipharmaceutics International Inc

July 23, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Second Quarter 2022 Results

July 21, 2022 | finance.yahoo.com

Intellipharmaceutics Announces Second Quarter 2022 Results

July 15, 2022 | ca.finance.yahoo.com

Stocks in play: Intellipharmaceutics International Inc.

April 14, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces First Quarter 2022 Results

April 1, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.

February 28, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Fiscal Year 2021 Results

January 13, 2022 | finanznachrichten.de

Intellipharmaceutics International Inc.: Intellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene Keirstead

January 7, 2022 | nasdaq.com

Intellipharmaceutics International Inc (IPCIF)

October 15, 2021 | finance.yahoo.com

Intellipharmaceutics Announces Third Quarter 2021 Results

August 21, 2021 | msn.com

'I fit here perfectly': Adames reflects on meteoric rise with Brewers

August 19, 2021 | msn.com

'He has allergies': Parents in Palm Beach County react to school district's updated stay-at-home order

August 9, 2021 | ft.com

‘If Masa said yes, who am I to object?’: SoftBank deals unleash internal compliance tensions

August 5, 2021 | msn.com

Some public health officials want R.I. to enforce masks indoors

August 5, 2021 | msn.com

Black and Latino caucus leader calls for R.I. to include minority-owned businesses

July 29, 2021 | msn.com

Black and Latino caucus calls for R.I. to comply with state contract requirement

July 23, 2021 | msn.com

Maharashtra again cuts up to 25% syllabus from class I to XII

July 20, 2021 | nytimes.com

Tiny Love Stories: ‘Who Was I to Deprive Him of Joy?’

July 20, 2021 | msn.com

Tones and I to quit music after worldwide success of Dance Monkey

July 19, 2021 | msn.com

Ryan Bridge: If a police officer says they need a weapon to do their job, who am I to stand in their way?

July 19, 2021 | msn.com

I’d always expected FBI agents to look a certain way, but John and Jane were nothing like that

July 18, 2021 | forbes.com

Ask Larry: Will Social Security's Earnings Test Require My Daughter And I To RePay Benefits?

July 16, 2021 | nytimes.com

Bourdain Documentary’s Use of A.I. to Mimic Voice Draws Questions

July 15, 2021 | msn.com

As four coaches depart University of Hartford after decision to leave Division I, John Gallagher makes a stand for the men’s basketball program

See More Headlines

Receive I Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

I Company Calendar

Today: 4/01/2023
Next Earnings (Estimated): 4/13/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Wireless Telecommunications
Sub-Industry: N/A
Sector: Business Services
Current Symbol: TSE:I
CUSIP: N/A
CIK: N/A
Web: www.intelsat.com
Phone: +1-416-7983001
Fax: N/A
Employees: 1,195
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 30,156,000
Free Float: N/A
Market Cap: C$97.40 million
Optionable: Optionable
Beta: N/A

Key Executives

Isa Odidi Ph.D.
Chairman of the Board, Chief Executive Officer

Amina Odidi Ph.D.
President, Chief Operating Officer, Director

Andrew Patient
Chief Financial Officer

John N. Allport
Vice President - Legal Affairs and Licensing, Secretary, Director

Patrick N. Yat Ph.D.
Vice President - Pharmaceutical Analysis and Chemistry

Kenneth Keirstead
Independent Director

Bahadur Madhani
Independent Director

Eldon R. Smith M.D. (Age 75)
Independent Director

Key Competitors

View All Competitors

I Stock - Frequently Asked Questions

When is Intellipharmaceutics International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, April 13th 2023.
View our I earnings forecast.
What other stocks do shareholders of Intellipharmaceutics International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Intellipharmaceutics International investors own include QuickLogic (QUIK), VBI Vaccines (VBIV), NeuLion (NLN), Micron Technology (MU), Mallinckrodt (MNK), Intellipharmaceutics International (IPCIF), Fitbit (FIT), Clean Commodities (CLE), Calithera Biosciences (CALA) and BlackBerry (BB).
What is Intellipharmaceutics International's stock symbol?: Intellipharmaceutics International trades on the Toronto Stock Exchange (TSX) under the ticker symbol "I."

How do I buy shares of Intellipharmaceutics International?: Shares of I stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
How much money does Intellipharmaceutics International make?: Intellipharmaceutics International (TSE:I) has a market capitalization of C$0.00.
How many employees does Intellipharmaceutics International have?: The company employs 1,195 workers across the globe.
How can I contact Intellipharmaceutics International?: Intellipharmaceutics International's mailing address is 30 Worcester Rd, ETOBICOKE, ON M9W 5X2, Canada. The official website for the company is www.intelsat.com. The company can be reached via phone at +1-416-7983001.

This page (TSE:I) was last updated on 4/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial